Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8648374rdf:typepubmed:Citationlld:pubmed
pubmed-article:8648374lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0460004lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C1517927lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0549178lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C1519810lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:8648374lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:8648374pubmed:issue4lld:pubmed
pubmed-article:8648374pubmed:dateCreated1996-7-25lld:pubmed
pubmed-article:8648374pubmed:abstractTextTo evaluate an intensive concomitant chemoradiotherapy protocol of conventional radiotherapy with intermittent cisplatin (CDDP) and continuous-infusion fluorouracil (5-FU) in unresectable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).lld:pubmed
pubmed-article:8648374pubmed:languageenglld:pubmed
pubmed-article:8648374pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8648374pubmed:citationSubsetIMlld:pubmed
pubmed-article:8648374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8648374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8648374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8648374pubmed:statusMEDLINElld:pubmed
pubmed-article:8648374pubmed:monthAprlld:pubmed
pubmed-article:8648374pubmed:issn0732-183Xlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:CvitkovicEElld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:EschwegeFFlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:LuboinskiBBlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:ArmandJ PJPlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:WibaultPPlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:DomengeCClld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:BorelCClld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:JankóEElld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:GuillotTTlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:de ForniMMlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:RecondoGGlld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:Tellez...lld:pubmed
pubmed-article:8648374pubmed:authorpubmed-author:BensmaineM...lld:pubmed
pubmed-article:8648374pubmed:issnTypePrintlld:pubmed
pubmed-article:8648374pubmed:volume14lld:pubmed
pubmed-article:8648374pubmed:ownerNLMlld:pubmed
pubmed-article:8648374pubmed:authorsCompleteYlld:pubmed
pubmed-article:8648374pubmed:pagination1192-200lld:pubmed
pubmed-article:8648374pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:meshHeadingpubmed-meshheading:8648374-...lld:pubmed
pubmed-article:8648374pubmed:year1996lld:pubmed
pubmed-article:8648374pubmed:articleTitleIntensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.lld:pubmed
pubmed-article:8648374pubmed:affiliationDepartment of Radiotherapy, Institut Gustave Roussy, Villejuif, France.lld:pubmed
pubmed-article:8648374pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8648374pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8648374pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8648374pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8648374lld:pubmed